XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Income and Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Molecular diagnostic testing $ 179,149us-gaap_SalesRevenueServicesNet $ 196,158us-gaap_SalesRevenueServicesNet $ 343,656us-gaap_SalesRevenueServicesNet $ 389,144us-gaap_SalesRevenueServicesNet
Pharmaceutical and clinical services 5,244us-gaap_OtherSalesRevenueNet 7,902us-gaap_OtherSalesRevenueNet 9,574us-gaap_OtherSalesRevenueNet 17,383us-gaap_OtherSalesRevenueNet
Total revenue 184,393us-gaap_Revenues 204,060us-gaap_Revenues 353,230us-gaap_Revenues 406,527us-gaap_Revenues
Costs and expenses:        
Cost of molecular diagnostic testing 35,050us-gaap_CostOfRevenue 22,755us-gaap_CostOfRevenue 67,847us-gaap_CostOfRevenue 44,194us-gaap_CostOfRevenue
Cost of pharmaceutical and clinical services 2,802mygn_CostOfPharmaceuticalAndClinicalServices 3,376mygn_CostOfPharmaceuticalAndClinicalServices 4,870mygn_CostOfPharmaceuticalAndClinicalServices 7,418mygn_CostOfPharmaceuticalAndClinicalServices
Research and development expense 17,504us-gaap_ResearchAndDevelopmentExpense 17,090us-gaap_ResearchAndDevelopmentExpense 40,116us-gaap_ResearchAndDevelopmentExpense 33,893us-gaap_ResearchAndDevelopmentExpense
Selling, general, and administrative expense 92,695us-gaap_SellingGeneralAndAdministrativeExpense 77,840us-gaap_SellingGeneralAndAdministrativeExpense 178,135us-gaap_SellingGeneralAndAdministrativeExpense 155,119us-gaap_SellingGeneralAndAdministrativeExpense
Total costs and expenses 148,051us-gaap_CostsAndExpenses 121,061us-gaap_CostsAndExpenses 290,968us-gaap_CostsAndExpenses 240,624us-gaap_CostsAndExpenses
Operating income 36,342us-gaap_OperatingIncomeLoss 82,999us-gaap_OperatingIncomeLoss 62,262us-gaap_OperatingIncomeLoss 165,903us-gaap_OperatingIncomeLoss
Other income (expense):        
Interest income 85us-gaap_InvestmentIncomeInterest 1,330us-gaap_InvestmentIncomeInterest 140us-gaap_InvestmentIncomeInterest 2,691us-gaap_InvestmentIncomeInterest
Other income (expense) 1,513us-gaap_OtherNonoperatingIncomeExpense (185)us-gaap_OtherNonoperatingIncomeExpense 1,416us-gaap_OtherNonoperatingIncomeExpense (623)us-gaap_OtherNonoperatingIncomeExpense
Total other income 1,598us-gaap_NonoperatingIncomeExpense 1,145us-gaap_NonoperatingIncomeExpense 1,556us-gaap_NonoperatingIncomeExpense 2,068us-gaap_NonoperatingIncomeExpense
Income before income taxes 37,940us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 84,144us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 63,818us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 167,971us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax provision 13,909us-gaap_IncomeTaxExpenseBenefit 33,784us-gaap_IncomeTaxExpenseBenefit 23,805us-gaap_IncomeTaxExpenseBenefit 62,146us-gaap_IncomeTaxExpenseBenefit
Net income 24,031us-gaap_NetIncomeLoss 50,360us-gaap_NetIncomeLoss 40,013us-gaap_NetIncomeLoss 105,825us-gaap_NetIncomeLoss
Earnings per share:        
Basic $ 0.33us-gaap_EarningsPerShareBasic $ 0.67us-gaap_EarningsPerShareBasic $ 0.55us-gaap_EarningsPerShareBasic $ 1.37us-gaap_EarningsPerShareBasic
Diluted $ 0.32us-gaap_EarningsPerShareDiluted $ 0.66us-gaap_EarningsPerShareDiluted $ 0.53us-gaap_EarningsPerShareDiluted $ 1.33us-gaap_EarningsPerShareDiluted
Weighted average shares outstanding        
Basic 72,467us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 75,070us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 72,615us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 77,323us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted 75,401us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 76,825us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 75,755us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 79,312us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Comprehensive income:        
Net income 24,031us-gaap_NetIncomeLoss 50,360us-gaap_NetIncomeLoss 40,013us-gaap_NetIncomeLoss 105,825us-gaap_NetIncomeLoss
Unrealized gain (loss) on available-for-sale securities, net of tax (145)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax 253us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax (277)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax 538us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Change in foreign currency translation adjustment, net of tax (1,669)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax (112)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax (2,390)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax 392us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
Comprehensive income $ 22,217us-gaap_ComprehensiveIncomeNetOfTax $ 50,501us-gaap_ComprehensiveIncomeNetOfTax $ 37,346us-gaap_ComprehensiveIncomeNetOfTax $ 106,755us-gaap_ComprehensiveIncomeNetOfTax